Trial Profile
Clinical Trials Insight: 700008831
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 04 Feb 2010
Price :
$35
*
At a glance
- Drugs Gabapentin enacarbil (Primary)
- Indications Restless legs syndrome
- Focus Therapeutic Use
- 24 Nov 2005 New trial record.